Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Pfizer and the Massachusetts Institute of Technology (MIT) have entered into a 10-year lease agreement for more than 180,000 sq² feet in a new building under development in Cambridge, Massachusetts.
Subscribe to our email newsletter
Pfizer will use the new site for its Cardiovascular, Metabolic and Endocrine Disease (CVMED) and Neuroscience Research Units.
PharmaTherapeutics R&D head and senior vice president Rod MacKenzie said they will provide the best environment for our researchers to invent the next generation of medicines in areas of greatest need, such as Alzheimer’s disease, schizophrenia,
The company expects to move into the new space when it is completed in the fourth quarter of 2013.